Inner Mongolia Medical University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Inner Mongolia China (1956)

Organization Overview

First Clinical Trial
2013
NCT01918241
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Affiliated Hospital of Inner Mongolia Medical University | Inner Mongolia Medical University affiliated Hospital | The Affiliated Hospital of Inner Mongolia Medical University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Esophageal Neoplasms (Phase 2)

Neutropenia (Phase 2)

Ovarian Hyperstimulation Syndrome (Phase 3)

Syndrome (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 20